Grandal, B.; Evrevin, C.; Laas, E.; Jardin, I.; Rozette, S.; Laot, L.; Dumas, E.; Coussy, F.; Pierga, J.-Y.; Brain, E.;
et al. Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers 2020, 12, 3681.
https://doi.org/10.3390/cancers12123681
AMA Style
Grandal B, Evrevin C, Laas E, Jardin I, Rozette S, Laot L, Dumas E, Coussy F, Pierga J-Y, Brain E,
et al. Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers. 2020; 12(12):3681.
https://doi.org/10.3390/cancers12123681
Chicago/Turabian Style
Grandal, Beatriz, Clémence Evrevin, Enora Laas, Isabelle Jardin, Sonia Rozette, Lucie Laot, Elise Dumas, Florence Coussy, Jean-Yves Pierga, Etienne Brain,
and et al. 2020. "Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy" Cancers 12, no. 12: 3681.
https://doi.org/10.3390/cancers12123681
APA Style
Grandal, B., Evrevin, C., Laas, E., Jardin, I., Rozette, S., Laot, L., Dumas, E., Coussy, F., Pierga, J.-Y., Brain, E., Saule, C., Stoppa-Lyonnet, D., Frank, S., Sénéchal, C., Lae, M., De Croze, D., Bataillon, G., Guerin, J., Reyal, F.,
& Hamy, A.-S.
(2020). Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers, 12(12), 3681.
https://doi.org/10.3390/cancers12123681
